Skip to main content

KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC

Position in GILD — Gilead Sciences, Inc.

CIK 1021223 LOS ANGELES, CA

Position in GILD

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$6,339,235
+$223,402 QoQ
Shares Held
50,176
+14.3% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#524
of 2,266 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority Sole 25% Shared 74% None 1%

Common Shares in GILD Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC holds $148,204,577 across 14 Drug Manufacturers - General names. GILD ranks #5 (4.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 GILD
Gilead Sciences, Inc.
This page
50,176 $6,339,235

All Filings in GILD

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $6,339,235 50,176
2026-03-31 $6,115,833 43,882
2025-12-31 $5,221,972 42,545
2025-09-30 $4,882,890 43,990
2025-06-30 $4,373,266 39,445
2025-03-31 $4,261,597 38,033
2024-12-31 $18,566 201
2024-09-30 $13,582 162
2024-06-30 $11,046 161
2024-03-31 $12,599 172
2023-12-31 $14,743 182
2023-09-30 $5,695 76
2023-06-30 $2,466 32
2023-03-31 $995 12
2022-06-30 $2,472 40
2022-03-31 $25,385 427
2021-12-31 $29,552 407
2021-09-30 $27,241 390
2021-06-30 $26,855 390
2021-03-31 $25,205 390
2020-12-31 $22,721 390
2020-09-30 $2,527 40
2020-06-30 $3,077 40
2020-03-31 $2,990 40